CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- S-3 Offering Registration Statement
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
- D Other Notice of Sales of Unregistered Securities
- 4 Open-market buy President and CEO bought 37,037 shares at $1.35 ($50,000)
- 4 Open-market buy Chief Business Officer bought 29,630 shares at $1.35 ($40,001)
- 4 Open-market buy Chief Financial Officer bought 7,407 shares at $1.35 ($9,999)
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
- 424B5 Offering Prospectus
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
Page 17 of 61 · 1,218 filings